WuXi AppTec Achieves Prestigious MSCI ESG AAA Leader Recognition

In a significant milestone for the company, WuXi AppTec, a leading global provider of research and development as well as manufacturing services in the pharmaceutical and life science sectors, announced that it has earned the prestigious AAA rating from MSCI. This rating, which represents the highest level of recognition for Environmental, Social, and Governance (ESG) performance, showcases WuXi AppTec as a pioneer among A-share listed companies in the life science space.

This achievement underscores the organization’s unwavering commitment to sustainability. Dr. Steve Yang, Co-CEO of WuXi AppTec, expressed his pride in this recognition, emphasizing that it validates the company's focus on integrating sustainable practices across all operations. "Receiving MSCI's highest ESG rating is an honor. It reflects our dedication to creating long-term value through responsible growth, aimed at a healthier future for patients and stakeholders alike," said Dr. Yang.

The MSCI ESG Rating System

MSCI is a renowned provider of critical decision-support tools and services tailored to the global investment community. Its ESG ratings assess companies based on financially relevant sustainability risks and opportunities. These evaluations allow investors to gain insight into a company's sustainable development performance, thereby aiding in informed investment decisions. The MSCI ESG rating scales range from AAA, the top tier, to CCC, the lowest rating. The AAA and AA ratings are deemed leader ratings, signifying superior ESG performance.

WuXi AppTec’s stellar performance in crucial areas, notably Product Safety and Quality, Human Capital Development, and Corporate Governance, contributed to its AAA leader rating. This rating marks an advancement from the company’s previous status, having maintained an AA rating for four consecutive years, demonstrating an ongoing commitment to ESG excellence.

Continuous Commitment to Sustainability

Furthermore, WuXi AppTec's commitment extends beyond just achieving top ESG ratings. The company has consistently integrated sustainability objectives into its operational strategies. The organization has been featured in the Dow Jones Sustainability Index (DJSI) for four continuous years, illustrating its reputation for sustainable operation practices. Moreover, the company also holds an A- Leadership rating in the CDP Climate Change assessment and has been recognized by Morningstar Sustainalytics as an Industry and Regional ESG Top-Rated Company.

In terms of water security, WuXi AppTec has earned an A Leadership rating in the CDP Water Security assessment. These accolades reflect the company’s dedication to sustainability and responsible business practices, which are integral to its identity.

Continuing its sustainability journey, WuXi AppTec has received validation for its near-term emissions reduction targets from the Science Based Targets Initiative (SBTi). Moreover, it is actively involved in the United Nations Global Compact (UNGC), championing its ten principles, and is a supplier partner of the Pharmaceutical Supply Chain Initiative (PSCI).

About WuXi AppTec

Founded with the vision that every drug can be manufactured and every disease can be treated, WuXi AppTec is committed to supporting healthcare innovation through its robust RD and manufacturing capabilities. Operating across Asia, Europe, and North America, the company offers a full spectrum of services via its unique CRDMO (Contract Research, Development, and Manufacturing Organization) platform. With nearly 6,000 partners worldwide, WuXi AppTec plays a pivotal role in helping bring groundbreaking therapies to market. Their dedication to advancing breakthrough medicines continues to guide their collaborative efforts with industry partners.

For more information on WuXi AppTec and its commitment to sustainability and healthcare innovation, visit www.wuxiapptec.com.